Layla Soroush

Array ( [id] => 9749821 [patent_doc_number] => 08841297 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-23 [patent_title] => 'Phenylimidazole derivative as PDE10A enzyme inhibitor' [patent_app_type] => utility [patent_app_number] => 13/378405 [patent_app_country] => US [patent_app_date] => 2010-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7967 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13378405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6340997 [patent_doc_number] => 20100247689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'Agent containing fat (oil), which contains onion extract, the production and use thereof for caring, preventing or treating damaged skin tissue, especially scarred tissue' [patent_app_type] => utility [patent_app_number] => 12/802250 [patent_app_country] => US [patent_app_date] => 2010-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10674 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247689.pdf [firstpage_image] =>[orig_patent_app_number] => 12802250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6599986 [patent_doc_number] => 20100292281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'TREATMENT OF MCI AND ALZHEIMER\'S DISEASE' [patent_app_type] => utility [patent_app_number] => 12/779345 [patent_app_country] => US [patent_app_date] => 2010-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 18567 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20100292281.pdf [firstpage_image] =>[orig_patent_app_number] => 12779345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6548110 [patent_doc_number] => 20100222367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'PYRAZINE KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/774376 [patent_app_country] => US [patent_app_date] => 2010-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11247 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20100222367.pdf [firstpage_image] =>[orig_patent_app_number] => 12774376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6271409 [patent_doc_number] => 20100255099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'CLAVULANATE FORMULATION FOR NEUROPROTECTION AND TREATMENT OF NEURODEGENERATIVE DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/770304 [patent_app_country] => US [patent_app_date] => 2010-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13024 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20100255099.pdf [firstpage_image] =>[orig_patent_app_number] => 12770304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6577336 [patent_doc_number] => 20100273838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'STABLE TOPICAL COMPOSITIONS FOR 1,2,4-THIADIAZOLE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/765981 [patent_app_country] => US [patent_app_date] => 2010-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7542 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0273/20100273838.pdf [firstpage_image] =>[orig_patent_app_number] => 12765981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6276208 [patent_doc_number] => 20100256193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'PHARMACEUTICAL FORMULATIONS COMPRISING NITROCATECHOL DERIVATIVES AND METHODS OF MAKING THEREOF' [patent_app_type] => utility [patent_app_number] => 12/750956 [patent_app_country] => US [patent_app_date] => 2010-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7705 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20100256193.pdf [firstpage_image] =>[orig_patent_app_number] => 12750956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6509737 [patent_doc_number] => 20100210703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'ANTI-FUNGAL FORMULATION' [patent_app_type] => utility [patent_app_number] => 12/750563 [patent_app_country] => US [patent_app_date] => 2010-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 39077 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210703.pdf [firstpage_image] =>[orig_patent_app_number] => 12750563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6514791 [patent_doc_number] => 20100216751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'Liquid Bevirimat Dosage Forms for Oral Administration' [patent_app_type] => utility [patent_app_number] => 12/731786 [patent_app_country] => US [patent_app_date] => 2010-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 31303 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216751.pdf [firstpage_image] =>[orig_patent_app_number] => 12731786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6569890 [patent_doc_number] => 20100234465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'Administration of Intravenous Ibuprofen' [patent_app_type] => utility [patent_app_number] => 12/722682 [patent_app_country] => US [patent_app_date] => 2010-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18832 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234465.pdf [firstpage_image] =>[orig_patent_app_number] => 12722682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6433450 [patent_doc_number] => 20100152303 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'AGENTS AND METHOD FOR INCREASING BRAIN CHAPERONIN LEVELS' [patent_app_type] => utility [patent_app_number] => 12/711944 [patent_app_country] => US [patent_app_date] => 2010-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8680 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20100152303.pdf [firstpage_image] =>[orig_patent_app_number] => 12711944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7656437 [patent_doc_number] => 20110305706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'Compositions and Methods for Treating a Disease Mediated by Soluble Oligomeric Amyloid Beta' [patent_app_type] => utility [patent_app_number] => 13/202838 [patent_app_country] => US [patent_app_date] => 2010-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7998 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20110305706.pdf [firstpage_image] =>[orig_patent_app_number] => 13202838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6509278 [patent_doc_number] => 20100210682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'Repeated Dosing of TRPV1 Antagonists' [patent_app_type] => utility [patent_app_number] => 12/709125 [patent_app_country] => US [patent_app_date] => 2010-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12577 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210682.pdf [firstpage_image] =>[orig_patent_app_number] => 12709125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6295431 [patent_doc_number] => 20100160267 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'Treatment of Inflammatory Bowel Disease With 2-Methylene-19-Nor-Vitamin D Compounds' [patent_app_type] => utility [patent_app_number] => 12/707358 [patent_app_country] => US [patent_app_date] => 2010-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5200 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20100160267.pdf [firstpage_image] =>[orig_patent_app_number] => 12707358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6509722 [patent_doc_number] => 20100210702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'ANTI-FUNGAL FORMULATION' [patent_app_type] => utility [patent_app_number] => 12/705555 [patent_app_country] => US [patent_app_date] => 2010-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 39073 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210702.pdf [firstpage_image] =>[orig_patent_app_number] => 12705555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6639039 [patent_doc_number] => 20100173993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'Controlled release biocidal salts' [patent_app_type] => utility [patent_app_number] => 12/658200 [patent_app_country] => US [patent_app_date] => 2010-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5359 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173993.pdf [firstpage_image] =>[orig_patent_app_number] => 12658200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6645075 [patent_doc_number] => 20100227900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'Use of Sulphur-Containing Heteroaromatic Acid Analogues as Bactericides' [patent_app_type] => utility [patent_app_number] => 12/699246 [patent_app_country] => US [patent_app_date] => 2010-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11046 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20100227900.pdf [firstpage_image] =>[orig_patent_app_number] => 12699246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7567049 [patent_doc_number] => 20110287112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'PROSTATE CANCER PROGRESSION INHIBITOR AND PROGRESSION INHIBITION METHOD' [patent_app_type] => utility [patent_app_number] => 13/147086 [patent_app_country] => US [patent_app_date] => 2010-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12190 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20110287112.pdf [firstpage_image] =>[orig_patent_app_number] => 13147086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7710405 [patent_doc_number] => 20120003310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'DELAYED RELEASE RASAGILINE FORMULATION' [patent_app_type] => utility [patent_app_number] => 13/145989 [patent_app_country] => US [patent_app_date] => 2010-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24973 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13145989 [rel_patent_id] =>[rel_patent_doc_number] =>)